Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
DLTx's founder is Timothy Furey.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
O3 Mining: Ambitious Growth Plans and Promising Resource Portfolio in Canada
00:10:00
The cryptocurrency enthusiasts looking to grow, learn, and invest|Amit Mukherjee,Founder and Managing Partner,Chainforest
00:10:00
Geopolitics and De-globalization: Their Impact on Upstream and Downstream Battery Materials
00:10:00
Steve Parsons on Goldsource Mines and Eagle Mountain Project Overview
00:10:00
From U.S. REITs to Global Real Assets Leadership | Bob Steers, Executive Chairman , Cohen & Steers Inc.
00:10:00
Explore Ormat Technologies' turbine evolution and production tour video with English subtitles on YouTube Kids.
00:10:00
Invests in fast-growing, revenue-stage Software, Marketplace, and eCommerce|William F. Detwiler,Co-Founder & Managing Partner,Fernbrook Capital Management
00:10:00
Addressing Legal and Ethical Challenges in Targeted Killing: A Conceptual Framework|Abraham D. Sofaer
00:10:00
Demystifying Structured Products: Insights and Strategies for Investors | Craig Novorr - President and CIO of Paragon Capital Management, Ltd.
00:10:00
Exploring New Lithium Pegmatites and Geophysics Discoveries at Mount Alexander
00:10:00
I'm Still Waiting For My Big Break|Talia Goldberg,Partner,Bessemer Venture Partners
00:10:00
We invest in people over product at the earliest stage of the entrepreneurial journey|Charles Hudson, Managing Partner, Precursor Ventures